The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARDN.L Regulatory News (ARDN)

  • There is currently no data for ARDN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

1 May 2020 07:00

RNS Number : 5287L
Arden Partners plc
01 May 2020
 

Arden Partners plc

("Arden" or the "Company")

 

Trading Update

 

Arden is today issuing a trading update in respect of the six-month period ended 30 April 2020.

 

Arden made a good start to the six-month trading period despite it encompassing the elevated political uncertainty around Brexit and then the General Election. Trading towards the end of the period has been impacted by the significant global market declines in reaction to the COVID-19 pandemic.

 

Compared to the performance in the six months ended 30 April 2019, we anticipate materially higher corporate finance revenues, higher retainer levels but lower equity commissions. The equity trading operation suffered material losses as markets fell in response to COVID-19.

 

The Board has implemented steps to reduce the Company's cost base. As a result, the Company's current annual cost base is anticipated to be more than 25% lower than last year. The measures taken include salary and fee sacrifices for all Board members and certain senior employees of in excess of 40% of salary; salary sacrifices for all other employees; the furloughing of a number of staff and the cancellation or deferral of all discretionary expenditure. Arden will also defer the payment of VAT in line with the government's proposals. The Board will continue to take action to reduce costs and minimise the financial impact of the uncertainty caused by COVID 19.  

 

Before taking into account the equity trading book losses, Arden expects to report a profit for the six-month period. After taking into account the equity trading book losses, Arden expects to report a reduced loss for the period compared to the prior year.

 

The Company has a strong balance sheet, with cash and cash equivalent resources well in excess of its regulatory requirements.   

 

Operationally, we responded to COVID-19 promptly and successfully implemented a comprehensive remote working capability, which has enabled us to ensure both the wellbeing of our staff and the ability to continue servicing our clients as normal. The Company is fully operational and continues to operate as normal. Due to the quality and flexibility of our people and the strengths of our business, our ability to attract and win new high-quality corporate clients remains strong. We continue to sign up quality clients and have a good pipeline going forward.

 

We are working closely with our corporate clients to assess the disruption caused by COVID-19 and, where possible, assist them in protecting their businesses and continuing to implement their strategies. Our aim is to fully support all corporate and institutional clients during these unprecedented times.

 

Mark Ansell, Chairman, commented:

 

"The COVID-19 crisis has presented unprecedented challenges to our business. However, it remains in a strong financial position and we have taken the necessary actions to enable us to confront the current market environment without harming our ability to fully service our clients. The Board is indebted to the Company's employees for their hard work and ongoing support in light of these challenges.

 

The Board's priorities remain to protect the Company's balance sheet and to deliver on our stated growth strategy."

 

 

For further information, please contact:

 

Arden Partners plc

 

020 7614 5900

Donald Brown - Chief Executive Officer

James Reed-Daunter - Executive Director

Steve Douglas - Group Finance Director

 

GCA Altium Limited (NOMAD)

 

020 7484 4040

Tim Richardson

 

 

Notes for editors:

 

Arden is a dedicated corporate adviser and multi-service stockbroker to small and mid-cap companies in the UK and their investors.

 

The absolute core of our business is the effective management of the needs of our significant and growing base of corporate clients, and the effective support of their relationships with existing and potential shareholders. 

 

These relationships are enhanced by the quality of our corporate finance advice and industry research, and the strong market presence of our sales and trading teams.

 

Our corporate finance capabilities encompass M&A, corporate finance advisory, broking and Sponsor and NOMAD services. We represent our clients in private transactions and AIM and Main Market share issues.

 

Our research is designed to be sector focused, concentrating on top down thematic trends which highlight companies giving investors an exposure to the real growth areas of the small-cap and AIM markets.

 

It is the job of the sales team to keep institutions abreast of these themes and stock ideas. When there is a requirement for our corporate clients to raise money to fulfil their growth ambitions, the sales team is in a strong position to effect this, with its entrenched relationships with the UK institutional and non-institutional markets.

 

Our market making and trading teams provide liquidity in the shares of our corporate clients. We also trade the shares of non-client corporates on behalf of institutions.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKKKBNBBKDQQN
Date   Source Headline
3rd Jul 201712:45 pmRNSHolding(s) in Company
3rd Jul 201712:44 pmRNSHolding(s) in Company
30th Jun 20178:56 amRNSDirector/PDMR Shareholding
29th Jun 201711:07 amRNSResult of Meeting and Total Voting Rights
12th Jun 20178:21 amRNSResult of Placing
12th Jun 20177:01 amRNSProposed Placing
12th Jun 20177:00 amRNSInterim Results - Six Months Ended 30 April 2017
25th May 20177:00 amRNSDirectorate Changes and Possible Fundraising
13th Apr 201711:50 amRNSForm 8.5 (EPT/NON-RI)
3rd Apr 201711:50 amRNSForm 8.5 (EPT/NON-RI)
31st Mar 201711:50 amRNSForm 8.5 (EPT/NON-RI)
15th Mar 20178:21 amRNSPossible offer by Dolphin for FIH Group
9th Mar 201712:17 pmRNSResult of AGM
9th Mar 201710:57 amRNSAGM Statement
13th Feb 201711:31 amRNSBlock Listing Six Monthly Return
7th Feb 20172:40 pmRNSPublication of Annual Report and Notice of AGM
3rd Feb 201711:28 amRNSTransaction in Own Shares and Total Voting Rights
1st Feb 20172:09 pmRNSProposed Award of Share Options
26th Jan 20177:00 amRNSPreliminary Results - Year Ended 31 October 2016
6th Jan 201711:50 amRNSForm 8.5 (EPT/NON-RI)
20th Dec 201611:50 amRNSForm 8.5 (EPT/NON-RI)
5th Dec 201612:30 pmRNSForm 8.5 (EPT/NON-RI) AMENDMENT
1st Dec 201611:50 amRNSForm 8.5 (EPT/NON-RI)
30th Nov 201611:50 amRNSForm 8.5 (EPT/NON-RI)
21st Nov 201612:17 pmRNSForm 8.5 (EPT/NON-RI)
2nd Nov 201611:50 amRNSForm 8.5 (EPT/NON-RI)
28th Oct 201612:27 pmRNSHolding(s) in Company
28th Oct 201612:12 pmRNSHolding(s) in Company
28th Oct 201611:03 amRNSHolding(s) in Company
28th Oct 201610:44 amRNSHolding(s) in Company
28th Oct 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Oct 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Oct 20167:00 amRNSPersonnel Change
6th Oct 201611:50 amRNSForm 8.5 (EPT/NON-RI)
4th Oct 201611:50 amRNSForm 8.5 (EPT/NON-RI)
26th Sep 201611:49 amRNSForm 8.5 (EPT/NON-RI)
20th Sep 201611:50 amRNSForm 8.5 (EPT/NON-RI)
16th Sep 20162:19 pmRNSForm 8.5 (EPT/NON-RI)
19th Aug 201612:08 pmRNSHolding(s) in Company
12th Aug 201611:25 amRNSBlocklisting Six Monthly Return
11th Aug 201610:10 amRNSForm 8.5 (EPT/NON-RI)
2nd Aug 20167:00 amRNSDirector/PDMR Shareholding
1st Aug 20167:30 amRNSChange of Name of Nominated Adviser
28th Jul 20167:00 amRNSInterim Results - Six Months Ended 30 April 2016
21st Jul 201611:50 amRNSForm 8.5 (EPT/NON-RI)
11th Jul 201611:23 amRNSForm 8.5 (EPT/NON-RI)
15th Jun 201611:50 amRNSForm 8.5 (EPT/NON-RI)
9th Jun 20169:44 amRNSForm 8.5 (EPT/NON-RI)
7th Jun 201611:50 amRNSForm 8.5 (EPT/NON-RI)
3rd Jun 201611:50 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.